issues
October 2026
Download PDFCOVER
SPECIAL REPORT - Excited About Excipients?
Kurt R. Sedo and Cindy H. Dubin take a deep dive into the excipient market, highlighting how new excipients enable advanced drug products and how AI and computation tools are helping match excipients to APIs.
FEATURES
FORMULATION FORUM - Oral Delivery of Nanocrystal Suspensions
Dr. Shaukat Ali and Dr. Jim Huang shed light on the challenges and opportunities to improve solubility and enhance oral bioavailability of molecules in nanocrystals or crystalline suspensions.
DRUG DELIVERY - Powder to Patient: Advancing Reconstitutable Injectables Through Integrated Aseptic Powder Filling & Next-Generation Dual Chamber Delivery
Laxman Halleppanavar and David Phasey offer a focused perspective on connecting formulation, particle engineering, aseptic manufacturing, device design, and patient use within one scalable development pathway.
SILICONE CHEMISTRY - Modification of Silicone Chemistry & Its Influence on Release Rates of APIs
Matthew Kihara explains how silicone lends itself to optimization, customization, and therapeutic performance, and that modifying silicone chemistry presents an opportunity to optimize drug release behavior and system performance.
VACCINE TECHNOLOGY - Delivering Better Global Vaccination Programs by Removing the Needle, Syringe & Fridge
Robin Cohen says that novel vaccine technology does not relate simply to the antigen, but also to method of administration and route of delivery, stressing that removing needle, syringe, and refrigerator are a step toward better vaccination programs.
SPECIAL FEATURE - Excipients: Strategic Enablers of Innovation
Ahead of CPHI, Cindy H. Dubin learns from leading excipient suppliers how multi-functional and organic excipients are impacting novel formulations and how AI is becoming a valuable tool in formulation development.
EXECUTIVE INTERVIEW - Lonza: From Formulation to Scale-Up: Advancing Dry Powder Inhalation for Biologics
Dr. Kim Shepard and Dr. Beatriz Fernandes talk about the evolving respiratory delivery landscape, the technologies shaping the field, and development strategies for addressing formulation while initiating risk mitigation.
CONTROLLED RELEASE - Alginate Beads for Oral Drug Delivery: Formulation Strategies for Controlled Release & Enhanced Bioavailability
Vardan Ter-Antonyan, Casey Kikendall, and John Davis review the formulation principles governing calcium alginate bead performance and discuss the relationship between bead structure and controlled release.
ARTIFICIAL INTELLIGENCE - AI Has Transformed the Pharmacovigilence Landscape
Raj More surveys the field of AI tools and looks at some emerging trends as well as factors that will influence the development of these platforms.
EXECUTIVE INTERVIEW - Bone Biologics Corp.: Recombinant Protein Development in Engineering Active Orthobiologics & Targeted Bone Therapies
Jeffrey Frelick describes how Bone Biologics’ lead proprietary recombinant human protein is addressing the challenge of balancing strong bone growth with patient safety.
LIFE SCIENCE PERSPECTIVE - A Validated Modality Changes the Equation
Kelly Page shares her personal perspective on taking therapeutic modalities across the finish line and how she applies what she learns into future programs to turn scientific progress into improved patient outcomes.
